SCHEMBL15910477

SCHEMBL15910477

Cc1cc(C)c2cc(C3=NC(C)(C)Cc4ccccc43)cnc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 3/20 0.53
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
KDM4E B2RXH2 3/20 0.43
APAF1 O14727 1/20 0.43
MITF O75030 1/20 0.43
TDP2 O95551 1/20 0.43
NSD2 O96028 1/20 0.43
MAPT P10636 1/20 0.43
MPI P34949 1/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 3/20 0.42
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 3/20 0.38
GAA P10253 2/20 0.38
PKM P14618 1/20 0.37
CYP2D6 P10635 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15944504 0.87 KDM4E (0.40) PSMB5PDGFRBPDGFRAKDM4EAPAF1
SCHEMBL15944503 0.85 ALDH1A1 (0.44) PDGFRBPDGFRAKDM4EAPAF1MITF
SCHEMBL15910549 0.83 LMNA (0.45) PDGFRBPDGFRAKDM4EAPAF1MITF
SCHEMBL4522982 0.82 LMNA (0.50) PDGFRBPDGFRAKDM4EAPAF1MITF
SCHEMBL2905923 0.81 KDM4E (0.49) KDM4EAPAF1MITFTDP2NSD2
SCHEMBL15910504 0.78 KDM4E (0.50) PDGFRBPDGFRAKDM4EAPAF1MITF
SCHEMBL4517075 0.78 LMNA (0.46) KDM4EAPAF1MITFTDP2NSD2
SCHEMBL20300789 0.78 ALDH1A1 (0.44) KDM4EAPAF1MITFTDP2NSD2
SCHEMBL15910480 0.78 LMNA (0.44) PDGFRBPDGFRAKDM4EAPAF1MITF
SCHEMBL4507229 0.77 LMNA (0.43) PDGFRBPDGFRAKDM4EAPAF1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499515-B2 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same MITSUI CHEMICALS AGRO, INC. (JP) 2016-11-22 US disclosed
US-9499515-B2 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same MITSUI CHEMICALS AGRO, INC. (JP) 2016-11-22 US disclosed
US-9499515-B2 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same MITSUI CHEMICALS AGRO, INC. (JP) 2016-11-22 US disclosed
EP-2762474-B1 PRODUCTION METHODS FOR 3,4-DIHYDROISOQUINOLINE DERIVATIVES, AND PRODUCTION INTERMEDIATES FOR SAME MITSUI CHEMICALS AGRO INC (JP) 2016-02-24 EP disclosed
EP-2762474-B1 PRODUCTION METHODS FOR 3,4-DIHYDROISOQUINOLINE DERIVATIVES, AND PRODUCTION INTERMEDIATES FOR SAME MITSUI CHEMICALS AGRO INC (JP) 2016-02-24 EP disclosed
US-20160039786-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2016-02-11 US disclosed
US-20160039786-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2016-02-11 US disclosed
US-20160039786-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2016-02-11 US disclosed
US-9193706-B2 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same MITSUI CHEMICALS AGRO, INC. (JP) 2015-11-24 US disclosed
US-9193706-B2 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same MITSUI CHEMICALS AGRO, INC. (JP) 2015-11-24 US disclosed
US-9193706-B2 Method for producing 3,4-dihydroisoquinoline derivatives and production intermediates of same MITSUI CHEMICALS AGRO, INC. (JP) 2015-11-24 US disclosed
US-20140228576-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2014-08-14 US disclosed
US-20140228576-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2014-08-14 US disclosed
US-20140228576-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2014-08-14 US disclosed
EP-2762474-A1 PRODUCTION METHODS FOR 3,4-DIHYDROISOQUINOLINE DERIVATIVES, AND PRODUCTION INTERMEDIATES FOR SAME Mitsui Chemicals Agro, Inc. (JP) 2014-08-06 EP disclosed
CN-103814022-A Process for producing 3, 4-dihydroisoquinoline derivative and intermediate for producing the same MITSUI CHEMICALS AGRO INC 2014-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039786-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME SDHA, NDUFS3, GOT2 PSMB5 1799/4885PDGFRB 4050/4885PDGFRA 3560/4885
US-20140228576-A1 METHOD FOR PRODUCING 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND PRODUCTION INTERMEDIATES OF SAME SDHA, NDUFS3, GOT2 PSMB5 1799/4885PDGFRB 4050/4885PDGFRA 3560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.